DR. ALAN SOLOMON, M.D.
Medical Practice at Alcoa Hwy, Knoxville, TN
License number
Tennessee MD0000005589
Category
Medical Practice
Type
Specialist
Address
Address
1924 Alcoa Hwy, Knoxville, TN 37920
Phone
(865) 544-9165
(865) 544-6865 (Fax)
(865) 544-6865 (Fax)
Organization information
See more information about ALAN SOLOMON at bizstanding.comU T Medical Center - Alan Solomon MD
1924 Alcoa Hwy #U2, Knoxville, TN 37920
Categories:
Hematology Physicians & Surgeons, Medical Research & Development, Oncology Physicians & Surgeons, ...
Phone:
(865) 305-9165 (Phone)
Alan Solomon MD
1924 Alcoa Hwy, Knoxville, TN 37920
Status:
Inactive
Industry:
Medical Doctor's Office
Medical Doctor, Owners:
Roger Alan Brooksbank Medical Doctor, inactive,Alan Robb Mclean Medical Doctor, inactive,Mark Alan Washington Medical Doctor, inactive,...
Professional information
Dr. Alan Solomon, Knoxville TN - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
U T MEDICAL CTR
1924 Alcoa Hwy STE 2177, Knoxville 37920
(865) 544-9165 (Phone), (865) 544-6865 (Fax)
SOLOMON, ALAN MD
2705 Riverside Dr, Knoxville 37914
(865) 524-5087 (Phone)
1924 Alcoa Hwy STE 2177, Knoxville 37920
(865) 544-9165 (Phone), (865) 544-6865 (Fax)
SOLOMON, ALAN MD
2705 Riverside Dr, Knoxville 37914
(865) 524-5087 (Phone)
Certifications:
Internal Medicine, 1964
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
U T MEDICAL CTR
1924 Alcoa Hwy STE 2177, Knoxville 37920
SOLOMON, ALAN MD
2705 Riverside Dr, Knoxville 37914
University of Tennessee Medical Center
1924 Alcoa Hwy, Knoxville 37920
1924 Alcoa Hwy STE 2177, Knoxville 37920
SOLOMON, ALAN MD
2705 Riverside Dr, Knoxville 37914
University of Tennessee Medical Center
1924 Alcoa Hwy, Knoxville 37920
Education:
Medical School
Duke University
Graduated: 1957
Mount Sinai Hospital
Montefiore Medical Center
Rockefeller Inst
Duke University
Graduated: 1957
Mount Sinai Hospital
Montefiore Medical Center
Rockefeller Inst
Professor Of Medicine At University Of Tennessee
Position:
Professor of Medicine at University of Tennessee
Location:
Knoxville, Tennessee Area
Industry:
Biotechnology
Work:
University of Tennessee
-
Professor of Medicine
Education:
Duke
Alan Solomon, Knoxville TN
Specialties:
Internal Medicine, Hematology & Oncology
Work:
Hematology Oncology Consultant
1924 Alcoa Hwy, Knoxville, TN 37920 Gatop
2705 Riverside Dr, Knoxville, TN 37914
1924 Alcoa Hwy, Knoxville, TN 37920 Gatop
2705 Riverside Dr, Knoxville, TN 37914
Education:
Duke University(1957)
Methods Of Investigating, Diagnosing, And Treating Amyloidosis
US Patent:
7485616, Feb 3, 2009
Filed:
Apr 5, 2001
Appl. No.:
09/825872
Inventors:
Alan Solomon - Knoxville TN, US
Jonathan Stuart Wall - Knoxville TN, US
Rudi Hrncic - Knoxville TN, US
Maria Schell - Knoxville TN, US
Jonathan Stuart Wall - Knoxville TN, US
Rudi Hrncic - Knoxville TN, US
Maria Schell - Knoxville TN, US
Assignee:
University of Tennessee Research Foundation - Knoxville TN
International Classification:
A61K 38/00, A61K 38/17
US Classification:
514 2, 514 12, 530350, 5303871, 4241301, 424 91
Abstract:
The present invention provides a therapeutic method for removing amyloid fibrils from a patient. The present invention also provides a transgenic animal that develops systemic AA amyloidosis within three weeks for use as a tool to investigate AA amyloidosis and to evaluate agents that may be potentially useful in preventing and treating amyloid-related disorders. Further, the present invention provides diagnostic assays for monitoring immunoglobulin light chain fibrillogenesis in real-time and for identification of the chemical nature of the protein in amyloid deposits which enables the determination of the type of amyloidosis for therapeutic and prognostic purposes.
Methods For Amyloid Removal Using Anti-Amyloid Antibodies
US Patent:
2003014, Aug 7, 2003
Filed:
May 21, 1999
Appl. No.:
09/316387
Inventors:
ALAN SOLOMON - KNOXVILLE TN, US
RUDI HRNCIC - KNOXVILLE TN, US
JONATHAN STUART WALL - KNOXVILLE TN, US
RUDI HRNCIC - KNOXVILLE TN, US
JONATHAN STUART WALL - KNOXVILLE TN, US
International Classification:
A61K039/395
US Classification:
424/132100, 424/141100, 424/146100
Abstract:
Methods and related immunoglobulin peptides and fragments thereof are disclosed that enhance the cell-mediated immune response of a patient to deposits of amyloid fibrils. These methods exploit the opsonizing effect of antibodies directed toward amyloid material or its component parts.
Diagnostic And Therapeutic Potential Of Immune Globulin Intravenous (Igiv) Products
US Patent:
2009023, Sep 17, 2009
Filed:
Apr 13, 2006
Appl. No.:
11/911506
Inventors:
Brian O'Nuallain - Knoxville TN, US
Rudi Hrncic - Orange Park FL, US
Jonathan S. Wall - Knoxville TN, US
Alan Solomon - Knoxville TN, US
Rudi Hrncic - Orange Park FL, US
Jonathan S. Wall - Knoxville TN, US
Alan Solomon - Knoxville TN, US
International Classification:
A61K 51/00, A61K 49/00, A61B 5/055, A61B 8/00, A61K 39/395, C07K 1/16
US Classification:
424 149, 424 91, 424 934, 424 95, 4241301, 5303871
Abstract:
The present invention provides IGIV and IGIV enriched for binding to amyloid fibrils and to partially denatured amyloidogenic precursor polypeptides. The present invention also provides methods for obtaining IGIV enriched for binding to amyloid fibrils and to partially denatured amyloidogenic precursor polypeptides. The IGIV recognizes amyloid fibrils and partially denatured amyloidogenic precursor polypeptides. They are useful for treating diseases and conditions associated with amyloid deposition. The IGIV of the present invention also are useful for diagnosing and detecting amyloid deposition.
Preparation Of Purified Covalently Cross-Linked Abeta Oligomers And Uses Thereof
US Patent:
2009024, Oct 1, 2009
Filed:
Oct 14, 2008
Appl. No.:
12/251277
Inventors:
Brian O'Nuallain - Dublin, IE
Alan Solomon - Knoxville TN, US
Jonathan S. Wall - Knoxville TN, US
Luis Acero - Knoxville TN, US
Angela Williams - Knoxville TN, US
Alan Solomon - Knoxville TN, US
Jonathan S. Wall - Knoxville TN, US
Luis Acero - Knoxville TN, US
Angela Williams - Knoxville TN, US
Assignee:
University of Tennessee Research Foundation - Knoxville TN
International Classification:
A61K 39/395, C12P 21/00, C07K 1/00, C07K 16/18, G01N 33/53
US Classification:
4241301, 435 681, 530402, 530413, 5303871, 435 71
Abstract:
The present invention provides a method of purifying cross-linked oligomers. The purified cross-linked oligomers are useful as immunogen for generating and isolating cross-linked oligomer reactive antibodies. The cross-linked oligomer reactive antibodies are useful for detecting amyloid deposition and for diagnosing and treating diseases and conditions associated with amyloid deposition.
Odontogenic Ameloblast-Associated Protein As A Tumor Biomarker
US Patent:
2009023, Sep 24, 2009
Filed:
Mar 19, 2009
Appl. No.:
12/383009
Inventors:
Daniel P. Kestler - Maryville TN, US
Alan Solomon - Knoxville TN, US
James S. Foster - Knoxville TN, US
Charles L. Murphy - Norris TN, US
Alan Solomon - Knoxville TN, US
James S. Foster - Knoxville TN, US
Charles L. Murphy - Norris TN, US
International Classification:
C12Q 1/02
US Classification:
435 29
Abstract:
Odontogenic ameloblast-associated (ODAM) protein may be used as an effective biomarker in humans for various cancers, especially those of epithelial origin, such as breast, lung, and stomach. The ODAM protein may be detected in cancerous cells. Additionally, the blood of patients with such cancers contains high titers of anti-ODAM antibodies.
Methods For Amyloid Removal Using Anti-Amyloid Antibodies
US Patent:
8105594, Jan 31, 2012
Filed:
Jan 25, 2010
Appl. No.:
12/693085
Inventors:
Alan Solomon - Knoxville TN, US
Rudi Hrncic - Knoxville TN, US
Jonathan Stuart Wall - Knoxville TN, US
Rudi Hrncic - Knoxville TN, US
Jonathan Stuart Wall - Knoxville TN, US
International Classification:
A61K 39/395
US Classification:
4241351, 4241331, 4241521, 4241721
Abstract:
Methods and related immunoglobulin peptides and fragments thereof are disclosed that enhance the cell-mediated immune response of a patient to deposits of amyloid fibrils. These methods exploit the opsonizing effect of antibodies directed toward amyloid material or its component parts.
Method For Detecting And Diagnosing Disease Caused By Pathological Protein Aggregation
US Patent:
6063636, May 16, 2000
Filed:
Jan 19, 1996
Appl. No.:
8/605294
Inventors:
Fred J. Stevens - Naperville IL
Elizabeth A. Myatt - Riverside IL
Alan Solomon - Knoxville TN
Elizabeth A. Myatt - Riverside IL
Alan Solomon - Knoxville TN
Assignee:
The United States of America as represented by the United States
Department of Energy - Washington DC
The University of Tennessee - Knoxville TN
Department of Energy - Washington DC
The University of Tennessee - Knoxville TN
International Classification:
G01N 3002
US Classification:
436 86
Abstract:
A method is provided for detecting pathological macromolecules in a patient, comprising obtaining body fluid from the patient, pretreating the body fluid, subjecting the pretreated body fluid to size-exclusion chromatography to create an excluded fluid, and analyzing the excluded fluid to detect macromolecules having a predetermined molecular weight. The method also allows for comparing elution spectra with reference spectra of suspect pathologic proteins.